Injective (INJ) is currently trading at $3.65, exhibiting a 24-hour change of 1.75%. The price has experienced a daily range between a low of $3.45 and a high of $3.76, indicating a relatively stable trading environment with a volatility of 0.31%.

Trading volume stands at approximately $60.6 million, contributing to a volume-to-market cap ratio of 16.58%. This level of trading activity suggests a reasonable interest in INJ, though it remains lower than levels seen during more volatile periods in the past.

The moving averages reveal mixed signals: the 8 and 13-period SMAs are both declining, while the 21-period SMA shows slight growth. The 55-period SMA is showing a positive trend, but the 144-period SMA indicates a longer-term bearish outlook, down 7.54% from its price.

The RSI metrics present a nuanced picture; the 1-hour RSI at 55 suggests a neutral market sentiment, while the 7-day RSI at 39 indicates that INJ may be oversold. Furthermore, the significant price declines over the past 7, 14, and 30 days (17.55%, 23.82%, and 26.03%, respectively) indicate persistent bearish pressure that could influence short-term trading strategies.

Given the current price relative to historical highs, the all-time high of $52.62 remains a distant target, emphasizing the need for recovery in market sentiment. The overall technical indicators suggest that while there is some short-term stabilization, the longer-term trend remains bearish.

Based on this analysis, the recommendation for Injective (INJ) is to Hold. The current price shows potential for recovery if it can break above key resistance levels, but the significant declines and mixed moving averages warrant caution before entering new positions.